GAD2 and Autoimmunity: To determine whether β-cell specific-reactive T cell autoimmunity is participated in the pathogenesis of FT1D, we used ELISPOT assays to detect T cell response to GAD65, insulin B9–23 peptide, or C peptide in 10 FT1D patients, and 10 healthy controls.